The chitosan-containing polysaccharide is prepared by a method comprising the steps of heat-treating a fungus in a concentrated aqueous caustic alkali solution; subjecting the resulting solution to a solid-liquid separation treatment; di... H Okazaki,T Hamaya,S Kurihara - EP 被引量: 19发表: 0...
Fluoride-induced changes in the activities of sucrose metabolizing enzymes in relation to starch accumulation in sorghum caryopsis, raised through liquid c... Effect of sodium fluoride (10-50 mM) on the activities of sucrose metabolizing enzymes and alkaline inorganic pyrophosphatase in relation to the...
Please refer to the specific buffer information in the hard copy of CoA. 运输方式:In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice ...
FormLiquid Purification MethodAntigen affinity purification Storage BufferPBS with 0.02% sodium azide and 50% glycerol pH 7.3. Storage ConditionsStore at -20°C. Stable for one year after shipment.Aliquoting is unnecessary for -20oC storage.20ul sizes contain 0.1% BSA. ...
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C. 公司简介 湖北艾普蒂生物工程有限公司(简称:艾普蒂)由在国内科研试剂领域有着十几年从业经验的专业技术团队和企业管理团队组建而成,专门从事以抗体、蛋白、...
Liquid formulations of acid-labile drugs are provided. The formulations\ngenerally comprise micro-granules comprising an acid-labile drug coated with\nan enteric coating and a liquid vehicle having a pH less than 6 The\ncomponents of the formulation can separately provided in the form of kits. ...
Cited in 1 publications. PPIL4 antibody for WB, IF/ICC, IP, ELISA and reacts with human, mouse, rat.
Form Lyophilized or Liquid Tested applications WB,ELISA Species reactivity Human,Mouse Host Species Rabbit Purity Affinity purification Immunogen Information: Immunogen Recombinant fusion protein of human PPIL2 . Calculated molecular weight 58kDa/59kDa Observed molecular weight 70kDa Swiss Prot Q13356 Gene...
For modified release of the active ingredient, the oral pharmaceutical formulation in an aqueous suspension form of the microcapsules The invention relates to liquid pharmaceutical formulations for oral administration with the modified release of active principle(s), excluding amoxicillin, said formulations ...
humidity. Sampling was performed after 0, 7, 14, 21, and 28 days of refrigeration. Mesocarp slices (~1 cm thick) were frozen in liquid nitrogen and stored at –80 °C. Three replicates, consisting of 10 fruits/replicate, were taken at each time point for biochemical and molecular ...